Basit öğe kaydını göster

dc.contributor.authorKoksal, Deniz
dc.contributor.authorKoksal, Aydin Seref
dc.contributor.authorGurakar, Ahmet
dc.date.accessioned2019-12-10T10:54:50Z
dc.date.available2019-12-10T10:54:50Z
dc.date.issued2016
dc.identifier.issn2225-0719
dc.identifier.urihttps://doi.org/10.14218/JCTH.2016.00024
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075009/
dc.identifier.urihttp://hdl.handle.net/11655/14693
dc.description.abstractPrimary biliary cirrhosis (PBC) is a chronic progressive cholestatic liver disease caused by diffuse inflammation, destruction and fibrosis of the intrahepatic bile ducts, ultimately leading to cirrhosis, portal hypertension and liver failure. The pathogenesis of PBC is incompletely understood, but current data suggest roles for genetic susceptibility and environmental factors. PBC is often thought of as an organ-specific autoimmune disease, which mainly targets the liver; however, lung tissue is also a site for autoimmune involvement of PBC. The pulmonary manifestations of PBC include abnormalities in gas transfer and pulmonary function, subclinical alveolitis, interstitial lung disease, granulomatous lung disease, airway disease, pulmonary hypertension, pulmonary hemorrhage and pleural effusion.
dc.relation.isversionof10.14218/JCTH.2016.00024
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titlePulmonary Manifestations Among Patients With Primary Biliary Cirrhosis
dc.typeinfo:eu-repo/semantics/article
dc.relation.journalJournal of Clinical and Translational Hepatology
dc.contributor.departmentGöğüs Hastalıkları
dc.identifier.volume4
dc.identifier.issue3
dc.identifier.startpage258
dc.identifier.endpage262
dc.description.indexPubMed


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster